SGS Expands Viral Trials: ‘Less Volunteers, Less Cost to Client’
SGS says the expansion of its Belgian unit will offer a new approach in its clinical trials involving smaller sample sizes.
Archives for February 14, 2013
Protalix Looks to Capitalize on Plant-Based Manufacturing Technology
Protalix Biotherapeutics is attempting to use its US FDA-approved Gaucher's disease treatment as a proof of concept and springboard for its plant-based cell manufacturing technology.
PPD Expands Central Lab Services in Brussels, Singapore
PPD has expanded its central lab testing services at its Brussels and Singapore labs and will offer additional services in microbiology, peripheral blood mononuclear cell and molecular pathology services.